What a great time at Antibody Engineering & Therapeutics 2024! Our thaw and use cells, Fc Effector bioassays, and proteases sparked some meaningful conversations about improving biologics research workflows. Missed us at the event? You can still explore our literature library to learn more about how we can support your biologics research: https://bit.ly/4gkuuYH
About us
At Promega Corporation, creativity and connection drive discovery and innovation. We celebrate scientific discovery and the creative application of science to solve problems. Interactions with our customers, partners and vendors are central to everything we do, and we value those relationships. We seek out and build connections across the globe and in our local communities because creative problem solving requires a network of diverse ideas and viewpoints. We develop and evolve technologies and instrumentation in collaboration with scientists and researchers around the globe. From simple cloning vectors used to address fundamental questions in biology to bioluminescent assays that help us monitor food safety and water quality, we work side-by-side with our partners in academic, industrial and government institutions to bring the best minds to bear on the toughest questions. Since 1978, we have done this all with a steadfast commitment to sustainable business models that protect our environment, inspire and develop our employees as individuals, support the wellbeing and growth of our communities, and strengthen our relationships with our customers. With 16 branches around the world, Promega products are used by a global community of life scientists who are asking fundamental questions about biological processes as well as by scientists who are applying scientific knowledge to diagnose and treat diseases, discover new therapeutics, and use genetics and DNA testing for human identification.
- Website
-
http://www.promega.com
External link for Promega Corporation
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Madison, WI
- Type
- Privately Held
- Founded
- 1978
- Specialties
- Nucleic Acid Isolation, Protein Expression and Analysis, Cell-Based and Biochemical Assays, Luminescent Chemistries, Custom Manufacturing, Custom Assay Services, Energy Metabolism, Reporter Bioasssays, Nucleic Acid Amplification, and Protein Degradation
Locations
Employees at Promega Corporation
Updates
-
Your work is unique, so your reagents should be too. We create custom reagents that meet your exact specifications—from specialized formulations to tailored packaging. Partner with us to enhance your workflows and ensure reliable, reproducible results. Discover more: https://bit.ly/4gA8J6Y
-
-
Want to know more about how targeted protein degradation is redefining drug discovery? We are proud to sponsor the educational short course “Exploring Targeting Protein Degradation: Concepts and Applications” at #SLAS2025. This session, led by industry experts, offers a deep dive into the mechanisms and applications of targeted protein degradation (TPD), focusing on new modalities like PROTACs and molecular glues that harness the cell’s natural ubiquitin-proteasome system to selectively degrade proteins. Short Course Highlights: -Understand the foundations of TPD, including the ubiquitin-proteasome system, PROTACs and Glues. -Explore key strategies for designing and optimizing degrader compounds. -Learn about screening methods, in vivo evaluation, and clinical development. This short course is ideal for industry scientists, graduate students, and researchers interested in the potential of TPD to address challenging targets. Don’t miss this opportunity to deepen your expertise in this transformative field. Register now to secure your spot: https://bit.ly/4010paT
-
-
What if no therapeutic target was truly 'undruggable'? Explore the science reshaping the boundaries of drug discovery. Access the on-demand sessions from Illuminating New Frontiers: Cracking the Undruggable Code, a virtual event where world-class experts shared the latest advancements in tackling previously inaccessible drug targets. From cutting-edge research in RNA and induced proximity to new therapeutic strategies for RAS pathways, this event dives into the innovations shaping the future of drug discovery. Watch On-Demand Now: https://bit.ly/4gEbynb
-
-
A novel enzyme developed by Promega eliminates confounding stutter artifacts in STR analysis. Read how they did it, and how it will impact the DNA forensics industry. https://bit.ly/4gxCLIw
-
The PowerPlex® 18E System is designed to meet the demands of European forensic laboratories. This innovative, 8-color STR multiplex system amplifies all 16 ENFSI-recommended loci, two gender-determining loci, and two quality indicators—all in a single multiplex. With all loci under 325bp, PowerPlex® 18E provides reliable results even with degraded or low-quality samples. Optimized for the Spectrum CE and Spectrum Compact CE Systems, the PowerPlex® 18E System is the perfect solution for challenging forensic cases. Learn more: https://bit.ly/4goDIDi
-
-
Photosynthetic bacteria, have been quietly shaping our planet for billions of years. Responsible for producing the oxygen we breathe, these tiny organisms play a critical role in the global carbon cycle and are now stepping into the spotlight for another reason: their potential to both combat climate change. In this blog, we explore what makes two newly discovered cyanobacteria special and how this research could help address some of the world’s most pressing challenges. https://bit.ly/3DlhaVa
Hot Off the Seep: Novel Cyanobacteria with Hefty Implications for Carbon Cycling - Promega Connections
https://www.promegaconnections.com
-
🌟 Eccoli tutti i vincitori dell'edizione 2024 del Rising Researchers Award! 👏 Ancora complimenti a Federica, che con il suo progetto di ricerca "Development of a 3D model based on bioengineered scaffolds with human cells for skin regeneration" si è aggiudicata la vittoria per l'Italia e volerà a Madison (US) insieme agli altri finalisti. #Promega #RisingResearchersAward #RicercaScientifica
We are delighted to announce the Recipients of the 2024 Promega Rising Researchers Award. Let's recognize these brilliant #PhD scholars from around the globe together, for their significant contributions to scientific advancement in #lifescience. In 2025, we'll welcome them to our Promega Madison campus, for an exclusive immersive experience designed to expand their perspectives, build new connections, and inspire future discoveries. Join us in celebrating this exceptional group of scientists: Elahe Minaei, University of Wollongong | Gabriel Kaufmann, Vetmeduni | Yanti De Visser, KU Leuven | Beatriz Farias, Fundação Oswaldo Cruz (Fiocruz) | Ashwini Kedari, University of Helsinki | Julien BARTHELEMY, Cell Communication and Tumoral Microenvironment | Federica Trenta, Università degli Studi di Brescia | Eneko Garate Soraluze, Cima Universidad de Navarra | Louisa Dury, University of Zurich | Maureen K., Texas A&M University Congratulations to all - keep on Rising! 💫
-
Promega applies a long-term vision to business and planning, and we believe that caring for the environment is essential to reaching our goals. Learn more in our 2024 Corporate Responsibility Report. https://bit.ly/4fgUFxP
-
-
Thank you to everyone who visited us at the RNA-Targeted Drug Discovery Summit! It was a pleasure discussing how our technologies can advance your RNA research. Whether you’re looking to study RNA-protein interactions or splicing modulation in live cells or streamline RNA extraction workflows, we offer reliable solutions that can make your research more efficient. Check out our complete suite of tools designed to support RNA-targeting studies: https://bit.ly/4gD9RGU
-